|
MechanismEGFR antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CU |
First Approval Date28 Apr 2005 |
100 Clinical Results associated with Laboratorios PiSA SA de CV
0 Patents (Medical) associated with Laboratorios PiSA SA de CV
100 Deals associated with Laboratorios PiSA SA de CV
100 Translational Medicine associated with Laboratorios PiSA SA de CV